Note: This document contains side effect information about omidenepag isopropyl ophthalmic. Some dosage forms listed on this page may not apply to the brand name Omlonti.

Applies to omidenepag isopropyl ophthalmic: ophthalmic solution.

Side effects include:

The most common adverse reactions with incidence ≥1% are conjunctival hyperemia, photophobia, blurred vision, dry eye, instillation site pain, eye pain, ocular hyperemia, punctate keratitis, headache, eye irritation, and visual impairment.

For Healthcare Professionals

Applies to omidenepag isopropyl ophthalmic: ophthalmic solution.

Dermatologic

-Reversible pigmentation of the periorbital tissue occurred with the use of this drug.^[Ref]

Frequency not reported: Pigmentation^[Ref]

Ocular

Frequency not reported: Eyelash changes, iris pigmentation, vellus hair, ocular Inflammation, macular edema, cystoid macular edema^[Ref]

-Pigmentation of the iris is likely to be permanent after discontinuation.

-Eyelash changes include increased length, thickness, and the number of lashes or hairs. These changes are usually reversible upon discontinuation of treatment.^[Ref]

General

The most common adverse reactions reported were conjunctival hyperemia, photophobia, blurred vision, dry eye, instillation site pain, eye pain, ocular hyperemia, punctate keratitis, headache, eye irritation, and visual impairment.^[Ref]